Clinical Reviews
Physiology and Pharmacology of Ejaculation.
Basic Clin Pharmacol Toxicol. - 2016 : Oct;119 Suppl 3:18-25
Intracavernous injections in spinal cord injured men with erectile dysfunction, a systematic review and meta-analysis.
Ann Phys Rehabil Med. - 2016 : Sep;59S:e107
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Eur Urol - 2016 : Jul;70(1):124-33
Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis.
Eur Urol - 2016 : May;69(5):904-16.
The spinal control of ejaculation revisited: a systematic review and meta-analysis of anejaculation in spinal cord injured patients
Hum Reprod Update - 2013 : 2013 Sep-Oct;19(5):507-26
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Eur Urol. - 2011 : Oct ; 60(4):809-25.
Ejaculatory dysfunction (EjD) and its association with lower urinary tract symptoms of benign prostatic hyperplasia (LUTS/BPH) and BPH treatments
Urology - 2009 : May 8. [Epub ahead of print]
The pharmacological treatment of premature ejaculation
BJUInt. - 2008 : May15, [Epub ahead of print]
An Evidence-Based Definition of Lifelong Premature Ejaculation: Report of the International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Definition of Premature Ejaculation
BJUInt. - 2008 : 102(3):338-50
Efficacy and Safety of Tadalafil Once Daily: Considerations for the practical application of a new dosing option
Curr Med Res Opin. - 2008 : 24(12):3383-92
The Boston Area Community (BACH) Survey: Urologic and Sexual Symptoms Results or Origins from Physical or Behavioral Conditions Data Mining of the Submerged Portion of the Urology Iceberg.
Eur Urol. - 2007 : 52(2):326-30
How, why and when should urologists evaluate male sexual function
Nat Clin Pract Urol. - 2006 : 3(2):84-94
Impact of medical treatments for benign prostatic hyperplasia on sexual function
BJU International - 2006 : 97 (s2), 34-38
A Review of the Time of Onset and Duration of Clinical Efficacy of Phosphodiesterase Type-5 Inhibitors in the Treatment of Erectile Dysfunction
Urology - 2006 : 68(4):689-96
Research instruments for the diagnosis and treatment of patients with erectile dysfunction
Urology - 2006 : 68(3 Suppl):6-16
Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)
Eur. Urol. 47 - 2005 : 824–837
Genitourinary diseases
Drug Discovery Today: Therapeutic Strategies Vol. 2, No. 1 - 2005 : pp 1-52
Sexual medicine Sexual dyfunctions in men and women 2nd International Consultation on Sexual Dysfunctions
eds Health Publication Ltd, Oxford - 2004 : 990 p
Tadalafil: a novel treatment for erectile dysfunction.
European Heart Journal Supplements - 2002 : 4 (Supplement H), H24–H31
Oral drug therapy for erectile dysfunction
Urol. Clin. North Am. - 2001 : 28(2):321-34